Stay updated with breaking news from Controlled Release. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Israeli researchers have developed a cancer treatment using multi-drug nanoparticles by applying biological, chemical, and artificial intelligence (AI) technologies, the Israel Institute of Technology
JERUSALEM, Aug. 29 (Xinhua) -- Israeli researchers have developed a cancer treatment using multi-drug nanoparticles by applying biological, chemical, and artificial intelligence (AI) technologies, the Israel Institute of Technology said in a statement on Tuesday.
Planning underway for Phase 2 trial of LYT-300 in Fragile X-associated Tremor/Ataxia Syndrome LYT-300 is also being evaluated in a Phase 2a trial for anxiety disorders, and a Phase 2a in patients...
/PRNewswire/ -- The "Medical Devices Market Size, Share & COVID-19 Impact Analysis, By Type (Drug Delivery Devices, Diagnostic Devices, By Application, By...
The new silica nanoparticle can be loaded with temozolomide, a small molecule drug used to treat tumours known as glioblastoma.